Biohazardous Waste Transport Regulations: DOT and Federal Rules

Moving infectious waste across a city block — let alone across state lines — triggers a layered set of federal rules that most people outside the medical and waste management industries never see. The U.S. Department of Transportation, the Centers for Disease Control and Prevention, and the Environmental Protection Agency all have overlapping jurisdiction over how biohazardous materials move from point of generation to point of treatment or disposal. Getting the packaging, labeling, and documentation wrong isn't a paperwork inconvenience; it's the kind of violation that can result in civil penalties reaching $84,467 per day per violation under 49 U.S.C. § 5123 (Pipeline and Hazardous Materials Safety Administration, as adjusted for inflation). The full regulatory context for biohazard materials shapes everything that happens in this space.

Definition and scope

The DOT classifies infectious substances under Hazard Class 6.2, Division 6.2 in 49 CFR Part 173.134. That classification splits into two operative categories that determine nearly every downstream packaging and shipping decision:

The practical reality: most clinical specimens from hospital labs and physician offices move as Category B. Category A shipments are rare, heavily restricted, and largely confined to reference laboratories, biosafety level 4 research programs, and public health emergency response operations. For a detailed breakdown of the materials themselves, types of biohazardous materials covers the full spectrum.

How it works

Regulated medical waste transport doesn't happen informally. The federal framework operates in discrete, sequential steps.

  1. Classification — The generator determines whether the material is Category A, Category B, or exempt (e.g., patient specimens shipped for routine clinical testing under specific exemption criteria in 49 CFR 173.134(b)).
  2. Packaging — Materials are placed in compliant UN-specification packaging. Category A requires UN-certified outer packaging tested to IATA Packing Instruction 602 standards for air transport, or equivalent DOT standards for ground.
  3. Marking and labeling — Packages must bear the UN number, proper shipping name, and the biohazard symbol prescribed under 49 CFR 172.432. Category B packages require a UN3373 diamond mark with minimum 50mm × 50mm dimensions.
  4. Documentation — Shippers must prepare a Shipper's Declaration or, for ground transport of regulated medical waste, a Uniform Hazardous Waste Manifest if the material also qualifies as hazardous waste under 40 CFR Part 262 (EPA).
  5. Carrier qualification — Carriers transporting Division 6.2 materials must comply with 49 CFR Parts 390–397 (Federal Motor Carrier Safety Regulations) and, for air, with IATA Dangerous Goods Regulations. Training requirements under 49 CFR Part 172 Subpart H mandate hazmat employee training every 3 years.
  6. Tracking and recordkeeping — Records of hazardous materials shipments must be retained for 375 days from the date of acceptance by the carrier (49 CFR 172.201).

The CDC's Select Agent Program adds a parallel layer for materials containing select agents or toxins — a list that includes roughly 67 biological agents and toxins as of the program's most recent published list. Possession, use, or transfer of select agents requires institutional registration and specific shipping authorization that goes well beyond standard DOT compliance.

Common scenarios

Hospital or clinical lab to reference lab. A hospital sends a blood specimen with suspected viral hemorrhagic fever to a state public health lab. That shipment is Category A (UN2814), requires prior coordination with the receiving facility, and must be packaged by a trained shipper. The receiving lab must be registered with the CDC/USDA Select Agent Program if the pathogen is a select agent.

Physician's office to commercial lab. Routine blood draws and swabs destined for a commercial laboratory travel as Category B (UN3373) or, if meeting the patient specimen exemption criteria, as exempt. This represents the vast majority of clinical transport volume — millions of shipments annually through carriers like FedEx and UPS operating under their own dangerous goods programs aligned to IATA and DOT standards.

Medical waste hauler moving regulated medical waste. A licensed contractor picks up red-bag waste from a surgery center. This moves under state-regulated medical waste rules (which vary significantly by state) plus any applicable EPA hazardous waste rules — the EPA's regulated medical waste framework addresses how these layers interact at the federal level. The generator retains liability until the waste reaches a permitted treatment facility.

Decision boundaries

Three fault lines determine which ruleset applies to a given shipment.

Category A vs. Category B hinges on documented infectious capability in healthy hosts. When classification is genuinely uncertain, the more conservative Category A designation applies — a point DOT makes explicit in the preamble to the 49 CFR Part 173 rulemaking.

Infectious substance vs. regulated medical waste. DOT governs transport of infectious substances as defined in 49 CFR 173.134. EPA governs medical waste under the Resource Conservation and Recovery Act framework, though the federal Medical Waste Tracking Act of 1988 expired in 1991, leaving primary regulated medical waste authority to individual states. A shipment can simultaneously be a DOT-regulated Division 6.2 material and a state-regulated medical waste — compliance with both frameworks is required, not optional.

Domestic vs. international transport. Domestic ground shipments follow 49 CFR exclusively. Air transport within the U.S. on commercial carriers follows IATA Dangerous Goods Regulations (which incorporate ICAO Technical Instructions), even for purely domestic flights. International shipments layer WHO and destination-country requirements on top. The biohazardous waste disposal overview for the US addresses how treatment and disposal fit into the chain once transport is complete. For anyone navigating this topic from the beginning, the biohazard resource index provides orientation across all major subject areas.

References

Read Next

Regulatory Context for Bio Hazard The framework spans workplace safety, environmental protection, public health, and transportation, each domain governed by its... Types of Biohazardous Materials: A Comprehensive Reference This reference covers the major categories of biohazardous materials recognized under U.S. EPA Regulated Medical Waste Rules: Federal and State Compliance This page covers how EPA authority over medical waste is structured, how state programs inherit or extend that authority, and...